- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2019-08-22 16:35:26
- Reporting Period:
- Accepted Time:
- 2019-08-22 16:35:26
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1597264||Blueprint Medicines Corp||BPMC||Pharmaceutical Preparations (2834)||000000000|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1638468||L. Anthony Boral||C/o Blueprint Medicines Corporation |
45 Sidney Street
Cambridge MA 02139
|Chief Medical Officer||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Stock Option (Right to Buy)||Disposition||2019-08-20||1,300||$0.00||1,300||$8.80|
|Common Stock||Stock Option (Right to Buy)||Disposition||2019-08-21||8,700||$0.00||8,700||$8.80|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- Effected pursuant to a trading plan adopted on April 3, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.78 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.03 per share.
- This option was granted on February 10, 2015. This option vested with respect to 25% of the shares underlying the option on February 9, 2016 and as to an additional 1/48th of the shares underlying the option each month thereafter.